Enovix Shareholder Reminder: Early Warrant Expiration Price Condition
Enovix (Nasdaq: ENVX) announced that its common stock has traded above $10.50 for nine consecutive trading days since the distribution of warrants. The company's stock closed at $10.71 per share, with warrants trading at $1.96 in-the-money based on their $8.75 exercise price.
The warrants' earliest expiration date is set for August 19, 2025, contingent on the stock maintaining above $10.50 for 20 out of 30 trading days. CFO Ryan Benton noted that eleven trading days remain before potential warrant expiration, after which warrants will become non-tradable and non-exercisable.
Enovix (Nasdaq: ENVX) ha annunciato che il suo titolo ordinario ha superato la soglia di 10,50 $ per nove giorni di borsa consecutivi dalla distribuzione dei warrant. Il titolo ha chiuso a 10,71 $ per azione, con i warrant che si scambiavano a 1,96 $ in-the-money considerando il loro prezzo di esercizio di 8,75 $.
La data di scadenza pi霉 prossima dei warrant 猫 fissata per il 19 agosto 2025, a condizione che il titolo rimanga sopra i 10,50 $ per almeno 20 giorni di borsa su 30. Il CFO Ryan Benton ha sottolineato che restano undici giorni di negoziazione prima della possibile scadenza dei warrant, dopodich茅 questi non saranno pi霉 negoziabili n茅 esercitabili.
Enovix (Nasdaq: ENVX) anunci贸 que sus acciones ordinarias se han negociado por encima de $10.50 durante nueve d铆as consecutivos de mercado desde la distribuci贸n de los warrants. Las acciones cerraron a $10.71 por acci贸n, con los warrants cotizando a $1.96 in-the-money basados en su precio de ejercicio de $8.75.
La fecha de vencimiento m谩s pr贸xima de los warrants est谩 establecida para el 19 de agosto de 2025, condicionado a que las acciones mantengan un precio superior a $10.50 durante 20 de 30 d铆as de mercado. El CFO Ryan Benton se帽al贸 que quedan once d铆as de negociaci贸n antes de la posible expiraci贸n de los warrants, despu茅s de lo cual estos dejar谩n de ser negociables y ejercitables.
Enovix (雮橃姢雼�: ENVX)電� 氤错喌欤缄皜 鞗岆煱韸� 氚绊彫 鞚错泟 9瓯半灅鞚� 鞐办啀鞙茧 10.50雼煬 鞚挫儊 瓯半灅霅橃棃雼り碃 氚滍憸頄堨姷雼堧嫟. 須岇偓 欤检嫕鞚� 欤茧嫻 10.71雼煬鞐� 毵堦皭頄堨溂氅�, 鞗岆煱韸鸽姅 8.75雼煬 頄夓偓臧�瓴╈潉 旮办鞙茧 1.96雼煬 鞚鸽崝毹鸽媹 靸來儨搿� 瓯半灅霅橁碃 鞛堨姷雼堧嫟.
鞗岆煱韸胳潣 臧�鞛� 鞚措ジ 毵岅赴鞚检潃 2025雲� 8鞗� 19鞚�搿�, 欤缄皜臧� 30瓯半灅鞚� 欷� 20鞚� 鞚挫儊 10.50雼煬 鞚挫儊鞚� 鞙犾頃橂姅 臁瓣贝鞛呺媹雼�. CFO 霛检澊鞏� 氩ろ娂鞚� 鞗岆煱韸� 毵岅赴 臧�電レ澕旯岇 11瓯半灅鞚检澊 雮晿鞙茧┌, 鞚错泟鞐愲姅 鞗岆煱韸戈皜 瓯半灅 攵堦皜 氚� 頄夓偓 攵堦皜 靸來儨臧� 霅滊嫟瓿� 氚濏様鞀惦媹雼�.
Enovix (Nasdaq : ENVX) a annonc茅 que son action ordinaire s'est n茅goci茅e au-dessus de 10,50 $ pendant neuf jours de bourse cons茅cutifs depuis la distribution des bons de souscription. L'action a cl么tur茅 脿 10,71 $ par titre, les bons se n茅gociant 脿 1,96 $ dans la monnaie en fonction de leur prix d'exercice de 8,75 $.
La premi猫re date d'expiration des bons est fix茅e au 19 ao没t 2025, sous r茅serve que le cours de l'action reste au-dessus de 10,50 $ pendant 20 jours de bourse sur 30. Le directeur financier Ryan Benton a not茅 qu'il reste onze jours de n茅gociation avant la possible expiration des bons, apr猫s quoi ceux-ci deviendront non n茅gociables et non exer莽ables.
Enovix (Nasdaq: ENVX) gab bekannt, dass seine Stammaktien seit der Ausgabe der Warrants an neun aufeinanderfolgenden Handelstagen 眉ber 10,50 $ gehandelt wurden. Die Aktie schloss bei 10,71 $ pro Aktie, wobei die Warrants mit 1,96 $ im Geld gehandelt wurden, basierend auf ihrem Aus眉bungspreis von 8,75 $.
Das fr眉heste Ablaufdatum der Warrants ist auf den 19. August 2025 festgelegt, vorausgesetzt, die Aktie bleibt an 20 von 30 Handelstagen 眉ber 10,50 $. CFO Ryan Benton bemerkte, dass noch elf Handelstage bis zum m枚glichen Ablauf der Warrants verbleiben, danach werden die Warrants nicht mehr handelbar oder aus眉bbar sein.
- Warrants are currently $1.96 in-the-money, providing value for warrant holders
- Stock price maintaining strong performance above $10.50 threshold
- Potential dilution if warrants are exercised
- Limited time remaining for warrant holders to make decisions
Insights
Enovix warrant holders face potential early expiration as stock price meets 9 of 20 required days above $10.50 threshold.
Enovix Corporation has announced that its common stock has traded above
This development is significant for warrant holders who now face a potential accelerated timeline. If Enovix stock continues trading above the
The situation creates a strategic decision point for warrant holders who must now consider whether to:
- Exercise their warrants immediately to lock in the current
22.4% discount to market price - Sell their warrants on the open market to capture remaining time value
- Wait to see if the early expiration condition is met, recognizing the risk of potential value loss
For Enovix, if all warrants are exercised, this would represent an immediate capital infusion at the
Enovix Warrants: 9 of 9 Trading Days Above
FREMONT, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX, ENVXW) (鈥淐ompany鈥� or 鈥淓novix鈥�), a leader in advanced silicon battery technology, today announced that the price of its common stock has exceeded
The earliest expiration date for the Warrants remains August 19, 2025, subject to Enovix common stock continuing to trade above
Ryan Benton, Chief Financial Officer, stated, 鈥淲e鈥檝e now completed nine consecutive trading days out of the twenty days required to trigger early expiration. There may be as few as eleven trading days left prior to expiration of the Warrants, after which the Warrants will no longer be tradable or exercisable. In the meantime, we encourage shareholders to act according to the timeline that best fits their individual circumstances.鈥�
Enovix expects to provide further periodic updates, including if and when the Early Expiration Price Condition is met.
Further Information Relating to the Warrants
For more information relating to the exercise mechanics and other terms of the Warrants, please refer to the materials filed by the Company with the Securities and Exchange Commission (the 鈥淪EC鈥�) available at https://www.sec.gov and the information posted on the Company鈥檚 website at https://www.enovix.com/enovix-warrant-dividend.
About Enovix Corporation
Enovix is a leader in advancing lithium-ion battery technology with its proprietary cell architecture designed to deliver higher energy density and improved safety. The Company鈥檚 breakthrough silicon-anode batteries are engineered to power a wide range of devices from wearable electronics and mobile communications to industrial and electric vehicle applications. Enovix鈥檚 technology enables longer battery life and faster charging, supporting the growing global demand for high-performance energy storage. Enovix holds a robust portfolio of issued and pending patents covering its core battery design and manufacturing process.
Enovix is headquartered in Silicon Valley with facilities in India, South Korea and Malaysia. For more information visit聽聽and follow us on聽.
No Offer or Solicitation
This press release is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The issuance of the Warrants has not been registered under the Securities Act of 1933, as amended (the 鈥淪ecurities Act鈥�), as the distribution of a Warrant for no consideration does not constitute a sale of a security under Section 2(a)(3) of the Securities Act. A Form 8-A registration statement and prospectus supplement describing the terms of the Warrants were filed with the SEC and are available on the SEC鈥檚 website located at https://www.sec.gov. Holders of Warrants should read the prospectus supplement carefully, including the Risk Factors section included and incorporated by reference therein. This press release contains a general summary of the Warrants. Please read the Warrant Agreement filed as an exhibit to the Company鈥檚 Current Report on Form 8-K filed with the SEC on July 21, 2025 as it contains important information about the terms of the Warrants.
Forward鈥怢ooking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, about us, the Warrants and our business that involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance and can be identified by words such as anticipate, believe, continue, could, estimate, expect, intend, may, might, plan, possible, potential, predict, should, would and similar expressions that convey uncertainty about future events or outcomes. Forward-looking statements in this press release include, without limitation, our expectations regarding the Early Expiration Price Condition and the anticipated trading prices of our common stock. Actual results and outcomes could differ materially from these forward-looking statements as a result of certain risks and uncertainties, including, without limitation, those risks and uncertainties and other potential factors set forth in our filings with the SEC, including in the 鈥淩isk Factors鈥� and 鈥淢anagement鈥檚 Discussion and Analysis of Financial Condition and Results of Operations鈥� sections of our most recently filed annual report on Form 10-K and quarterly reports on Form 10-Q and other documents that we have filed, or that we will file, with the SEC. For a full discussion of these risks, please refer to Enovix鈥檚 filings with the SEC, including its most recent Form 10-K and Form 10-Q, available at https://ir.enovix.com and www.sec.gov. Any forward-looking statements made by us in this press release speak only as of the date on which they are made and subsequent events may cause these expectations to change. We disclaim any obligations to update or alter these forward-looking statements in the future, whether as a result of new information, future events or otherwise, except as required by law.
Investor Contact:
Robert Lahey
[email protected]
Chief Financial Officer:
Ryan Benton
[email protected]
FAQ
When do Enovix (ENVX) warrants expire?
What is the current exercise price for Enovix (ENVX) warrants?
How many trading days has Enovix (ENVX) stock traded above $10.50?
What happens to Enovix (ENVX) warrants after expiration?
What is the current trading price of Enovix (ENVX) stock?
